Ginkgo biloba : Cerebrovascular Health
B エビデンス 少なくとも1件のランダム化試験がこれを支持しており、おおむね一貫した結果が得られています。Research suggests Ginkgo may help enhance cerebral blood flow through vasodilation. More consistent benefits are observed for vascular-related cognitive symptoms than for general cognitive decline.
結論
Research suggests Ginkgo may help enhance cerebral blood flow through vasodilation. More consistent benefits are observed for vascular-related cognitive symptoms than for general cognitive decline.
Key Study Findings
対象集団: elderly patients with mild cognitive impairment or chronic brain diseases
対象集団: Male Sprague-Dawley rats with DVT model
対象集団: HT22 mouse hippocampal neurons under OGD/R
対象集団: APP/PS1 transgenic Alzheimer's disease mouse model
対象集団: Ischemic stroke patients (narrative review)
対象集団: BCAS cerebral small vessel disease mouse model
Key Statistics
12
研究数
2000
参加者数
Positive
グレード
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
一般的な使用量
- general:
- 120-240 mg/day standardized to 24% flavone glycosides and 6% terpene lactones
上限量: 600 mg/day (doses above show no additional benefit)
研究で検討された用量
| 用量 | 期間 | 効果 | N |
|---|---|---|---|
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | 10 weeks | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Positive | 22347 |
| None | -- | Positive | -- |
推奨摂取タイミング: With meals; may require 4-6 weeks for full effects
Safety & Side Effects
報告されている副作用
- ⚠ Headache
- ⚠ Gastrointestinal upset
- ⚠ Dizziness
- ⚠ Allergic skin reactions (rare)
- ⚠ Increased bleeding risk
既知の相互作用
- ● Anticoagulants and antiplatelet drugs (increased bleeding risk)
- ● Anticonvulsants (may reduce seizure threshold)
- ● SSRIs (serotonin syndrome risk, rare)
- ● CYP3A4 substrates (may affect drug metabolism)
耐容上限摂取量: 600 mg/day (doses above show no additional benefit)
サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。
Frequently Asked Questions
Does Ginkgo biloba help with Cerebrovascular Health?
How much Ginkgo biloba should I take for Cerebrovascular Health?
Are there side effects of Ginkgo biloba?
How strong is the evidence for Ginkgo biloba and Cerebrovascular Health?
Related Evidence
に関する他の成分: Cerebrovascular Health
Ginkgo biloba 他の症状・状態について
References
- [1] F Abad-Santos et al.. Rev Neurol. [Treatment of mild cognitive impairment: value of citicoline]. PubMed
- [2] Jinfa Du et al.. Proc Natl Acad Sci U S A. 2025. Identification of a central regulator of ginkgolide biosynthesis in Ginkgo biloba that integrates jasmonate and light signaling. doi:10.1073/pnas.2408891122 PubMed
- [3] Ting Yu et al.. Phytomedicine. 2025. Ginkgo biloba Extract GBE50 ameliorates cerebrovascular dysfunction and cognitive impairment in a mouse model of Alzheimer's disease. doi:10.1016/j.phymed.2025.156646 PubMed
- [4] Xing-Yuan Li et al.. J Ethnopharmacol. 2025. Inhibition of mitochondrial oxidative stress and apoptosis in the protection of Ginkgo biloba extract 50 against cognitive impairment. doi:10.1016/j.jep.2025.120059 PubMed
- [5] Cuicui Cheng et al.. Phytomedicine. 2025. Yindan Xinnaotong Soft Capsule improves post-ischemic stroke recovery by regulating CREB/BDNF-mediated synaptic plasticity and CREB/VEGFA-mediated angiogenesis. doi:10.1016/j.phymed.2025.157155 PubMed
- [6] Federico Masserini et al.. Alzheimers Dement. 2025. Therapeutic strategies in vascular cognitive impairment: A systematic review and meta-analysis. doi:10.1002/alz.70840 PubMed
- [7] S Sowmiya et al.. Front Pharmacol. 2025. Traditional, complementary, and integrative medicine in the management of ischemic stroke: a narrative review. doi:10.3389/fphar.2025.1561688 PubMed
- [8] H Yang et al.. Niger J Clin Pract. 2025. Antithrombotic Effect of Ginkgo Biloba Extract: A Study Based on Network Pharmacological Analysis and In vivo Experiments. doi:10.4103/njcp.njcp_770_24 PubMed
- [9] Dexiu Wang et al.. Metab Brain Dis. 2025. Ginkgo biloba extract mediates HT22 cell proliferation and migration after oxygen-glucose deprivation/reoxygenation via regulating RhoA-ROCK2 signalling pathway. doi:10.1007/s11011-024-01502-9 PubMed
- [10] Nasser M Aldekhail et al.. Altern Ther Health Med. 2025. Herbal Medicines in Autism Spectrum Disorder: Therapeutic Potential, Plant Components, and Dosage Guidelines. PubMed
- [11] Prabhash Nath Tripathi et al.. Degener Neurol Neuromuscul Dis. 2024. Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants. doi:10.2147/DNND.S452009 PubMed
- [12] Weile Ye et al.. Acta Pharm Sin B. 2024. [Not Available]. doi:10.1016/j.apsb.2023.09.014 PubMed
- [13] Liang-Yi Chen et al.. Physiol Rep. 2024. Anti-oxidative and anti-inflammatory effects of Ginkgo biloba extract (EGb761) on hindlimb skeletal muscle ischemia-reperfusion injury in rats. doi:10.14814/phy2.16050 PubMed
- [14] Qiuhong Zhu et al.. Pak J Pharm Sci. 2024. Clinical efficacy and mechanism of Ginkgo biloba extract in the treatment of elderly ischemic cerebrovascular disease. PubMed
- [15] Huan Han et al.. J Plant Physiol. 2023. Ginkgo biloba GbbZIP08 transcription factor is involved in the regulation of flavonoid biosynthesis. doi:10.1016/j.jplph.2023.154054 PubMed
- [16] Ting Yu et al.. Pharmaceutics. 2023. Ginkgo biloba Extract Drives Gut Flora and Microbial Metabolism Variation in a Mouse Model of Alzheimer's Disease. doi:10.3390/pharmaceutics15122746 PubMed
- [17] Tingchun Wu et al.. BMJ Open. 2023. Efficacy and safety of Ginkgo biloba dropping pills in the treatment of coronary heart disease with stable angina pectoris and … doi:10.1136/bmjopen-2021-055263 PubMed
- [18] Taizen Nakase et al.. PLoS One. 2023. Efficacy of a mixture of Ginkgo biloba, sesame, and turmeric on cognitive function in healthy adults: Study protocol for a … doi:10.1371/journal.pone.0280549 PubMed
- [19] Yanxia Liu et al.. J Ethnopharmacol. 2022. Leaves, seeds and exocarp of Ginkgo biloba L. (Ginkgoaceae): A Comprehensive Review of Traditional Uses, phytochemistry, pharmacology, resource utilization and … doi:10.1016/j.jep.2022.115645 PubMed
- [20] Min Xu et al.. J Integr Neurosci. 2022. Traditional medicine in China for ischemic stroke: bioactive components, pharmacology, and mechanisms. doi:10.31083/j.jin2101026 PubMed
- [21] José María García-Alberca et al.. Clin Drug Investig. 2022. Benefits of Treatment with Ginkgo Biloba Extract EGb 761 Alone or Combined with Acetylcholinesterase Inhibitors in Vascular Dementia. doi:10.1007/s40261-022-01136-8 PubMed
- [22] Fang Cao et al.. J Ethnopharmacol. 2022. Ginkgo biloba L. extract prevents steroid-induced necrosis of the femoral head by rescuing apoptosis and dysfunction in vascular endothelial cells … doi:10.1016/j.jep.2022.115476 PubMed
- [23] Li-Tao Wang et al.. Phytomedicine. 2022. Biflavonoids from Ginkgo biloba leaves as a novel anti-atherosclerotic candidate: Inhibition potency and mechanistic analysis. doi:10.1016/j.phymed.2022.154053 PubMed
- [24] Jie Zhang et al.. Gynecol Endocrinol. 2022. Ginkgo biloba extract 761 reduces vascular permeability of the ovary and improves the symptom of ovarian hyperstimulation syndrome in a … doi:10.1080/09513590.2022.2034147 PubMed
- [25] Jie Zhang et al.. Gynecol Endocrinol. 2022. Ginkgo biloba extract 761 reduces vascular permeability of the ovary and improves the symptom of ovarian hyperstimulation syndrome in a … doi:10.1080/09513590.2021.2011198 PubMed
- [26] Wen-Ming Yang et al.. Zhongguo Zhong Yao Za Zhi. 2022. [Expert consensus on clinical application of GBE50 Dispersible Tablets for ischemic cardiovascular and cerebrovascular diseases]. doi:10.19540/j.cnki.cjcmm.20210809.501 PubMed
- [27] Ju Wang et al.. Front Cell Neurosci. 2021. Traditional Chinese Medicine Monomers: Novel Strategy for Endogenous Neural Stem Cells Activation After Stroke. doi:10.3389/fncel.2021.628115 PubMed
- [28] Nagaendran Kandiah et al.. CNS Neurosci Ther. 2021. Strategies for the use of Ginkgo biloba extract, EGb 761® , in the treatment and management of mild cognitive impairment … doi:10.1111/cns.13536 PubMed
- [29] Shuang Zhao et al.. Evid Based Complement Alternat Med. 2021. The Clinical Efficacy of Ginkgo biloba Leaf Preparation on Ischemic Stroke: A Systematic Review and Meta-Analysis. doi:10.1155/2021/4265219 PubMed
- [30] Brittany R Block et al.. Sr Care Pharm. 2021. Online Promotion of "Brain Health" Supplements. doi:10.4140/TCP.n.2021.489 PubMed
- [31] Gang Gong et al.. Biomed Pharmacother. 2020. Isorhamnetin: A review of pharmacological effects. doi:10.1016/j.biopha.2020.110301 PubMed
- [32] Phui Zee Chong et al.. Am J Chin Med. 2020. Efficacy and Safety of Ginkgo biloba in Patients with Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. doi:10.1142/S0192415X20500263 PubMed
- [33] Dan Wu et al.. Zhongguo Zhong Yao Za Zhi. 2020. [Similarities and differences between Ginkgo biloba and Panax notoginseng in treatment of ischemic cerebrovascular disease]. doi:10.19540/j.cnki.cjcmm.20200313.402 PubMed
- [34] Nagaendran Kandiah et al.. CNS Neurosci Ther. 2019. Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba … doi:10.1111/cns.13095 PubMed
- [35] Egemen Savaskan et al.. Int Psychogeriatr. 2018. Treatment effects of Ginkgo biloba extract EGb 761® on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of … doi:10.1017/S1041610217001892 PubMed
- [36] Wei Zuo et al.. Aging Dis. 2017. Advances in the Studies of Ginkgo Biloba Leaves Extract on Aging-Related Diseases. doi:10.14336/AD.2017.0615 PubMed
- [37] Yinfeng Yang et al.. ACS Chem Biol. 2017. Systematic Investigation of Ginkgo Biloba Leaves for Treating Cardio-cerebrovascular Diseases in an Animal Model. doi:10.1021/acschembio.6b00762 PubMed
- [38] Philippa A Jackson et al.. Nutrients. 2016. DHA Supplementation Alone or in Combination with Other Nutrients Does not Modulate Cerebral Hemodynamics or Cognitive Function in Healthy Older … doi:10.3390/nu8020086 PubMed
- [39] Xinhua Zhou et al.. Evid Based Complement Alternat Med. 2016. Vascular Contributions to Cognitive Impairment and Treatments with Traditional Chinese Medicine. doi:10.1155/2016/9627258 PubMed
- [40] Ying Deng et al.. Phytother Res. 2016. Effect of Ginkgo Biloba Extract on the Pharmacokinetics and Metabolism of Clopidogrel in Rats. doi:10.1002/ptr.5691 PubMed
- [41] Kevin M Nash et al.. Integr Med Insights. 2015. Current Perspectives on the Beneficial Role of Ginkgo biloba in Neurological and Cerebrovascular Disorders. doi:10.4137/IMI.S25054 PubMed
- [42] Pedro Montes et al.. CNS Neurol Disord Drug Targets. 2015. Ginkgo biloba Extract 761: A Review of Basic Studies and Potential Clinical Use in Psychiatric Disorders. doi:10.2174/1871527314666150202151440 PubMed
- [43] Wen Zheng et al.. Proteomics. 2015. Improved metabolites of pharmaceutical ingredient grade Ginkgo biloba and the correlated proteomics analysis. doi:10.1002/pmic.201400258 PubMed
- [44] Imad A-J Thanoon et al.. Sultan Qaboos Univ Med J. 2012. Oxidative Stress and C-Reactive Protein in Patients with Cerebrovascular Accident (Ischaemic Stroke): The role of Ginkgo biloba extract. doi:10.12816/0003113 PubMed
- [45] Klaus P Ebmeier. Practitioner. 2010. Normal cognitive decline or dementia? PubMed
- [46] Oleksandr Napryeyenko et al.. J Neurol Sci. 2009. Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. doi:10.1016/j.jns.2009.02.353 PubMed
- [47] . Prescrire Int. 2007. Ginkgo and Alzheimer's disease: little or no different from placebo. PubMed
- [48] Zahoor Ahmad Shah et al.. Eur Neuropsychopharmacol. 2003. Ginkgo biloba normalises stress-elevated alterations in brain catecholamines, serotonin and plasma corticosterone levels. doi:10.1016/s0924-977x(03)00005-1 PubMed
- [49] Laura L Boles Ponto et al.. Ann Clin Psychiatry. 2003. Ginkgo biloba extract: review of CNS effects. doi:10.1023/a:1024688326023 PubMed
- [50] Victor S Sierpina et al.. Am Fam Physician. 2003. Ginkgo biloba. PubMed
- [51] Lauren T Bonner et al.. Med Clin North Am. 2002. Pharmacologic treatments of dementia. doi:10.1016/s0025-7125(02)00007-x PubMed
- [52] D J McKenna et al.. Altern Ther Health Med. 2001. Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. PubMed
- [53] B J Diamond et al.. Arch Phys Med Rehabil. 2000. Ginkgo biloba extract: mechanisms and clinical indications. doi:10.1016/s0003-9993(00)90052-2 PubMed
- [54] S Logani et al.. Life Sci. 2000. Actions of Ginkgo Biloba related to potential utility for the treatment of conditions involving cerebral hypoxia. doi:10.1016/s0024-3205(00)00741-4 PubMed
- [55] V Evans. J Neurosci Nurs. 2000. Herbs and the brain: friend or foe? The effects of ginkgo and garlic on warfarin use. doi:10.1097/01376517-200008000-00007 PubMed
- [56] W J Riedel et al.. Curr Opin Clin Nutr Metab Care. 1998. Nutrients, age and cognitive function. doi:10.1097/00075197-199811000-00017 PubMed
FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。